Skylight Therapeutics (Private limited company)
Skylight Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 1015.430.741. It was founded on 22-10-2024. Its registered office is in Leuven. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € -54 733 and a loss of € 57 733. Addrly gives it a financial health grade of D, on a scale from A (safest) to E (most at risk).
Information last updated on 07-10-2026.
Company information
Key figures of Skylight Therapeutics
| 2025 | |
|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -57 733 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -54 733 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 21 284 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -54 689 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - |
Financial estimate
Similar companies
Other companies in the same activity in Leuven.
| Company | Town |
|---|---|
| NELSON LABS | 3001 Leuven |
| CUE - GRAPHICS | 3001 Leuven |
| Antleron | 3001 Leuven |
| RAMDESIGN | 3001 Leuven |
| LIMITO | 3001 Leuven |
| BETTER3FRUIT | 3001 Leuven |
| HUAWEI TECHNOLOGIES RESEARCH & DEVELOPMENT BELGIUM | 3001 Leuven |
| reMYND | 3001 Leuven |
Frequently asked questions
Is Skylight Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists Skylight Therapeutics as active.
What is the VAT number of Skylight Therapeutics? The VAT number of Skylight Therapeutics is BE 1015.430.741.
When was Skylight Therapeutics founded? Skylight Therapeutics was founded on 22-10-2024.
What is the address of Skylight Therapeutics? The current registered office of Skylight Therapeutics is Gaston Geenslaan 2, 3001 Louvain.
When did Skylight Therapeutics last file annual accounts? The latest annual accounts of Skylight Therapeutics were filed on 31-08-2026.
Is Skylight Therapeutics financially healthy? Addrly gives Skylight Therapeutics a financial health grade of D, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Skylight Therapeutics profitable? The annual accounts of Skylight Therapeutics for 2025 show a loss of € 57 733.
What is the equity of Skylight Therapeutics? The equity of Skylight Therapeutics was € -54 733 at the close of the 2025 financial year.
Who are the directors of Skylight Therapeutics? The annual accounts of Skylight Therapeutics record 1 mandate. The name, role and dates are visible with a free account.
Can Skylight Therapeutics receive Peppol e-invoices? Yes. Skylight Therapeutics is registered on the Peppol network and can receive structured electronic invoices.
What does Skylight Therapeutics do? The main activity of Skylight Therapeutics is: Scientific research and development.